Recent Finacing
Recent Raise
PepGen develops peptide-conjugated antisense oligonucleotide therapeutics (EDOs/PPMOs) to enhance tissue delivery and safety—notably cardiac and skeletal muscle—for DMD, DM1, and other neuromuscular/neurologic disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
